Luocitabin
Brand Name: Luocitabin
Generic Name: Gemcitabine Hydrochloride
Active
Registration Number
DRP-15041
Dosage Form
Lyophilized Powder for IV Injection
Issuance Date
February 27, 2024
Expiry Date
March 27, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength200 mg
Packaging15 mL Type I Clear Glass Vial with Bromobutyl Rubber Stopper and Aluminum-Plastic Flip-off Seal (Box of 1's)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic (Pyrimidine Analogue)
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Gemcitabine HydrochlorideActive
Monograph: Gemcitabine